RE/MAX Holdings, Inc.
RE/MAX Holdings, Inc. (RMAX) Financial Performance & Income Statement Overview
Explore the financials of RE/MAX Holdings, Inc. (RMAX), including yearly and quarterly data on income, cash flow, and balance sheets.
RE/MAX Holdings, Inc. (RMAX) Income Statement & Financial Overview
Analyze RE/MAX Holdings, Inc.’s RMAX earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $74.47M | $72.47M | $78.48M | $78.45M |
| Cost of Revenue | $18.86M | $18.65M | $20.10M | $27.43M |
| Gross Profit | $55.60M | $53.81M | $58.38M | $51.03M |
| Gross Profit Ratio | $0.75 | $0.74 | $0.74 | $0.65 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $43.03M | $35.77M | $35.93M | $34.85M |
| Operating Expenses | $50.24M | $49.54M | $43.17M | $42.25M |
| Total Costs & Expenses | $69.10M | $68.20M | $63.27M | $62.28M |
| Interest Income | $908000.00 | $903000.00 | $885000.00 | $949000.00 |
| Interest Expense | $7.92M | $8.56M | $9.25M | $9.19M |
| Depreciation & Amortization | $6.59M | $7.07M | $7.24M | $7.40M |
| EBITDA | $13.15M | $16.83M | $22.45M | $23.57M |
| EBITDA Ratio | $0.18 | $0.23 | $0.29 | $0.30 |
| Operating Income | $5.37M | $4.27M | $15.21M | $16.18M |
| Operating Income Ratio | $0.07 | $0.06 | $0.19 | $0.21 |
| Other Income/Expenses (Net) | -$6.73M | -$8.55M | -$8.29M | -$8.51M |
| Income Before Tax | -$1.37M | -$4.28M | $6.92M | $7.66M |
| Income Before Tax Ratio | -$0.02 | -$0.06 | $0.09 | $0.10 |
| Income Tax Expense | $1.87M | -$8.36M | $3.51M | $1.47M |
| Net Income | -$1.96M | $5.80M | $966000.00 | $3.71M |
| Net Income Ratio | -$0.03 | $0.08 | $0.01 | $0.05 |
| EPS | -$0.10 | $0.31 | $0.05 | $0.20 |
| Diluted EPS | -$0.10 | $0.29 | $0.05 | $0.20 |
| Weighted Avg Shares Outstanding | $19.29M | $18.92M | $18.86M | $18.85M |
| Weighted Avg Shares Outstanding (Diluted) | $19.29M | $19.99M | $19.48M | $19.004M |
Financial performance has remained strong, with revenue growing from $78.45M in Q2 2024 to $74.47M in Q1 2025. Gross profit continued to perform well, with margins at 75% in the latest quarter. Operating income reached $5.37M in Q1 2025, holding a steady 7% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $13.15M. Net income dropped to -$1.96M, keeping EPS at -$0.10. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan